bpc 157 fda warning peptide not approved Most people hear “not approved” and immediately think unsafe or ineffective… but the reality is a lot more about economics than science. If something can't be patented, there's little incentive to Peptides like BPC-157 and TB-500
Description
The dyschromia presents with depigmented macules, due to loss of melanocytes from the cutaneous epidermis or loss of the ability to secrete melanin
others notice minimal or no effects
Targeted visceral fat reduction: One of the most important AOD9604 peptide benefits is its apparent effectiveness at reducing visceral adipose tissue
Your healthcare teams goal will be to continue them until its safe to stop (if possible)
